Akamatsu Y, Chida K, Miyoshi K, Kojima D, Nomura J-I, Setta K, Chiba T, Koji T, Fujiwara S, Kashimura H, Kubo Y, Ogasawara K (2023) Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a case series. Brain Hemorrhages. https://doi.org/10.1016/j.hest.2023.10.003

Article  Google Scholar 

Barker FG 2nd, Ogilvy CS (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a metaanalysis. J Neurosurg 84:405–414. https://doi.org/10.3171/jns.1996.84.3.0405

Bauer AM, Rasmussen PA (2014) Treatment of intracranial vasospasm following subarachnoid hemorrhage. Front Neurol 5:72. https://doi.org/10.3389/fneur.2014.00072

Article  PubMed  PubMed Central  Google Scholar 

Chiang VL, Claus EB, Awad IA (2000) Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage. Neurosurgery 46:28–35 discussion 35 – 26

Article  CAS  PubMed  Google Scholar 

Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ (2016) Endothelin Pharmacol Rev 68:357–418. https://doi.org/10.1124/pr.115.011833

Article  PubMed  Google Scholar 

Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, Tominaga T (2022) Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg 137:1707–1717. https://doi.org/10.3171/2022.2.Jns212914

Article  CAS  PubMed  Google Scholar 

Etminan N, Vergouwen MD, Ilodigwe D, Macdonald RL (2011) Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab 31:1443–1451. https://doi.org/10.1038/jcbfm.2011.7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francoeur CL, Mayer SA (2016) Management of delayed cerebral ischemia after subarachnoid hemorrhage. Crit Care 20:277. https://doi.org/10.1186/s13054-016-1447-6

Article  PubMed  PubMed Central  Google Scholar 

Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T (2017) Preventive effect of Clazosentan against Cerebral Vasospasm after clipping surgery for Aneurysmal Subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis 44:59–67. https://doi.org/10.1159/000475824

Article  CAS  PubMed  Google Scholar 

Ibrahim GM, Macdonald RL (2013) The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care 19:140–149. https://doi.org/10.1007/s12028-013-9860-z

Article  CAS  PubMed  Google Scholar 

Ido K, Kurogi R, Kurogi A, Nishimura K, Arimura K, Nishimura A, Ren N, Kada A, Matsuo R, Onozuka D, Hagihara A, Takagishi S, Yamagami K, Takegami M, Nohara Y, Nakashima N, Kamouchi M, Date I, Kitazono T, Iihara K (2020) Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older. PLoS ONE 15:e0230953. https://doi.org/10.1371/journal.pone.0230953

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japan Stroke Society (2023) Guideline 2021 for the treatment of stroke [Revised version 2023]. In. KYOWA KIKAKU, Tokyo, p 171

Google Scholar 

Kusaka G, Ishikawa M, Nanda A, Granger DN, Zhang JH (2004) Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 24:916–925. https://doi.org/10.1097/01.Wcb.0000125886.48838.7e

Article  CAS  PubMed  Google Scholar 

Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, Wu YC, Klebanoff LM, Raps EC, Solomon RA (2000) Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383–391. https://doi.org/10.1161/01.str.31.2.383

Article  CAS  PubMed  Google Scholar 

Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, Frey A, Roux S, Pasqualin A (2008) Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 39:3015–3021. https://doi.org/10.1161/strokeaha.108.519942

Article  CAS  PubMed  Google Scholar 

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N (2012) Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43:1463–1469. https://doi.org/10.1161/strokeaha.111.648980

Article  CAS  PubMed  Google Scholar 

Maeda T, Okawara M, Osakabe M, Yamaguchi H, Maeda T, Kurita H (2024) Initial real-world experience of clazosentan for subarachnoid hemorrhage in Japan. World Neurosurg X 21:100253. https://doi.org/10.1016/j.wnsx.2023.100253

Article  PubMed  Google Scholar 

Maruhashi T, Higashi Y (2021) An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage. Expert Opin Pharmacother 22:1601–1614. https://doi.org/10.1080/14656566.2021.1912013

Article  CAS  PubMed  Google Scholar 

Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W (2022) Japan Stroke Society Guideline 2021 for the treatment of stroke. Int J Stroke 17:1039–1049. https://doi.org/10.1177/17474930221090347

Article  PubMed  PubMed Central  Google Scholar 

Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, Holman R (2002) International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. J Stroke Cerebrovasc Dis 11:304–314. https://doi.org/10.1053/jscd.2002.130390

Article  PubMed  Google Scholar 

Muraoka S, Asai T, Fukui T, Ota S, Shimato S, Koketsu N, Nishizawa T, Araki Y, Saito R (2023) Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study. Neurosurg Rev 46:195. https://doi.org/10.1007/s10143-023-02104-2

Article  PubMed  Google Scholar 

Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635–642. https://doi.org/10.1016/s1474-4422(09)70126-7

Article  PubMed  Google Scholar 

Nishii R, Ohta T, Fukui N, Koyanagi M, Goto M, Takeda J, Fukumitsu R, Sunohara T, Takano Y, Teranishi K, Nakajima K, Naramoto Y, Yamamoto Y, Kawade S, Sakisuka R, Takamatsu T, Tokuda M, Tomita H, Yoshimoto M, Sakai N (2023) A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. https://doi.org/10.1016/j.hest.2023.11.007

Article  Google Scholar 

Peeyush Kumar T, McBride DW, Dash PK, Matsumura K, Rubi A, Blackburn SL (2019) Endothelial cell dysfunction and Injury in Subarachnoid Hemorrhage. Mol Neurobiol 56:1992–2006. https://doi.org/10.1007/s12035-018-1213-7

Article  CAS  PubMed  Google Scholar 

Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale (1988) J Neurosurg 68:985–986. https://doi.org/10.3171/jns.1988.68.6.0985

Article  Google Scholar 

Sakr Y, Dünisch P, Santos C, Matthes L, Zeidan M, Reinhart K, Kalff R, Ewald C (2016) Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension. Ann Intensive Care 6:25. https://doi.org/10.1186/s13613-016-0128-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shirao S, Yoneda H, Ishihara H, Kajiwara K, Suzuki M (2011) A proposed definition of symptomatic vasospasm based on treatment of cerebral vasospasm after subarachnoid hemorrhage in Japan: Consensus 2009, a project of the 25 Spasm Symposium. Surg Neurol Int 2:74. https://doi.org/10.4103/2152-7806.81968

Solomon RA, Fink ME, Lennihan L (1988) Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 23:699–704. https://doi.org/10.1227/00006123-198812000-00002

Article  CAS  PubMed  Google Scholar 

Stauffer BL, Westby CM, DeSouza CA (2008) Endothelin-1, aging and hypertension. Curr Opin Cardiol 23:350–355. https://doi.org/10.1097/HCO.0b013e328302f3c6

Article  PubMed  PubMed Central  Google Scholar 

Suwatcharangkoon S, Meyers E, Falo C, Schmidt JM, Agarwal S, Claassen J, Mayer SA (2016) Loss of consciousness at Onset of Subarachnoid Hemorrhage as an important marker of Early Brain Injury. JAMA Neurol 73:28–35. https://doi.org/10.1001/jamaneurol.2015.3188

Article  PubMed  Google Scholar 

Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K (2007) A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol 68:126–131 discussion 131 – 122. https://doi.org/10.1016/j.surneu.2006.10.037

Article  PubMed  Google Scholar 

Suzuki H, Kanamaru H, Kawakita F, Asada R, Fujimoto M, Shiba M (2021) Cerebrovascular pathophysiology of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Histol Histopathol 36:143–158. https://doi.org/10.14670/hh-18-253

Article  CAS  PubMed  Google Scholar 

Suzuki H, Nakajima H, Ichikawa T, Yasuda R, Okada T, Goto F, Ito S, Horiuchi Y, Kitano Y, Nishikawa H, Fujimoto M, Toma N (2023) Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. https://doi.org/10.1016/j.hest.2023.10.006

Article  Google Scholar 

Takahashi S, Akiyama T, Horiguchi T, Miwa T, Takemura R, Yoshida K (2020) Loss of consciousness at ictus and/or poor World Federation of Neurosurgical Societies grade on admission reflects the impact of EBI and predicts poor outcome in patients with SAH. Surg Neurol Int 11:40. https://doi.org/10.25259/sni_551_2019

Article  PubMed  PubMed Central